Abstract
Understanding of the full potential of the genome coding capacity demands a deep knowledge of the different pathways that control gene expression. Translation initiation in eukaryotic mRNAs is a highly regulated process that accounts for the last step of gene expression control. While most mRNAs initiate translation using the AUG triplet closest to the 5end, a growing number of mRNAs appear to follow different rules, giving rise to proteins that differ in their amino terminus. Internal ribosome entry site (IRES) elements provide an alternative to initiate translation that allow the use of internal start codons, sometimes located several hundred of residues away from the 5end of the mRNA, bypassing strong RNA structures. Therefore, they represent a strategy to increase genetic diversity without increasing genome length. The IRES sequences found in viral and cellular mRNAs do not show overall sequence similarity, albeit they perform a similar function. IRES elements in viral mRNAs constitute an efficient method to distinguish its own mRNA from that of the host, and thus facilitate its survival when cellular protein synthesis is impaired. Viral IRES exploit different strategies to recruit the translational machinery, including direct ribosome binding, eIF3 or eIF4G-mediated mechanism. Cellular IRES mediated-translation represents a regulatory mechanism that helps the cell to cope with transient stress. They may be grouped according to common tropism, stimulation by similar situations and expression of specific targets in differentiated cells. Protein mediated-ribosome binding is likely to enhance the efficiency of cellular IRES sequences under specific environments. This review is focused to discuss recent advances on functional IRES elements.
Keywords: mrna, ires, protein synthesis, new orfs, genetic diversity, eukaryotic genomes
Current Genomics
Title: Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Volume: 5 Issue: 3
Author(s): E. Martinez-Salas, O. Fernandez-Miragall, R. Reigadas, A. Pacheco and P. Serrano
Affiliation:
Keywords: mrna, ires, protein synthesis, new orfs, genetic diversity, eukaryotic genomes
Abstract: Understanding of the full potential of the genome coding capacity demands a deep knowledge of the different pathways that control gene expression. Translation initiation in eukaryotic mRNAs is a highly regulated process that accounts for the last step of gene expression control. While most mRNAs initiate translation using the AUG triplet closest to the 5end, a growing number of mRNAs appear to follow different rules, giving rise to proteins that differ in their amino terminus. Internal ribosome entry site (IRES) elements provide an alternative to initiate translation that allow the use of internal start codons, sometimes located several hundred of residues away from the 5end of the mRNA, bypassing strong RNA structures. Therefore, they represent a strategy to increase genetic diversity without increasing genome length. The IRES sequences found in viral and cellular mRNAs do not show overall sequence similarity, albeit they perform a similar function. IRES elements in viral mRNAs constitute an efficient method to distinguish its own mRNA from that of the host, and thus facilitate its survival when cellular protein synthesis is impaired. Viral IRES exploit different strategies to recruit the translational machinery, including direct ribosome binding, eIF3 or eIF4G-mediated mechanism. Cellular IRES mediated-translation represents a regulatory mechanism that helps the cell to cope with transient stress. They may be grouped according to common tropism, stimulation by similar situations and expression of specific targets in differentiated cells. Protein mediated-ribosome binding is likely to enhance the efficiency of cellular IRES sequences under specific environments. This review is focused to discuss recent advances on functional IRES elements.
Export Options
About this article
Cite this article as:
Martinez-Salas E., Fernandez-Miragall O., Reigadas R., Pacheco A. and Serrano P., Internal Ribosome Entry Site Elements in Eukaryotic Genomes, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349390
DOI https://dx.doi.org/10.2174/1389202043349390 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy Natural Compounds and Drug Discovery: Can Cnidarian Venom Play a Role?
Central Nervous System Agents in Medicinal Chemistry Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Recent Advances and Developments in Treatment Strategies Against Pancreatic Cancer
Current Clinical Pharmacology Isolation, Purification, Characterisation and Application of L-ASNase: A Review
Recent Patents on Biotechnology Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Current Pharmaceutical Design Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design Cellular Uptake of Cell-Penetrating Peptides
Drug Design Reviews - Online (Discontinued) Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Cholangiocarcinoma Therapeutics: An Update
Current Cancer Drug Targets Potential and Cytotoxicity of cis-Platinum Complex with Anti-tumor Activity in Combination Therapy
Recent Patents on Anti-Cancer Drug Discovery The Role of Foxp3 in Regulatory T Cell Differentiation and Function
Current Immunology Reviews (Discontinued) Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology Identification of Novel Potent Inhibitors Against Bcl-xL Anti-apoptotic Protein Using Docking Studies
Protein & Peptide Letters